Randomized Dose‐Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse ofPlasmodium vivaxMalaria in Thailand-Reference-Cited by-同舟云学术

Randomized Dose‐Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse ofPlasmodium vivaxMalaria in Thailand

Published:1999-10 Issue:4 Volume:180 Page:1282-1287
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Walsh Douglas S.,Looareesuwan Sornchai,Wilairatana Polrat,Heppner, Jr. D. Gray,Tang Douglas B.,Brewer Thomas G.,Chokejindachai Watcharee,Viriyavejakul Parnpen,Kyle Dennis E.,Milhous Wilbur K.,Schuster Brian G.,Horton John,Braitman David J.,Brueckner Ralf P.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/180/4/1282/17995426/180-4-1282.pdf

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum;Clinical Infectious Diseases;2023-02-16

2. Authors' response;Indian Journal of Medical Research;2023

3. Tafenoquine for the radical cure versus prophylaxis of Plasmodium vivax malaria: the importance of using the appropriate data set;Indian Journal of Medical Research;2023

4. The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis;eLife;2022-12-06

5. Characterizing the blood stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected withPlasmodium falciparum;2022-11-22